[Steps to personalized therapy of multiple sclerosis: predicting safety of treatment using mathematical modeling].

Aim: To construct a mathematical model capable of predicting the drug safety of a patient receiving multiple sclerosis disease modifying drugs (DMD), on a model of flu-like syndrome (FLS).

Material And Methods: The study included 457 patients with multiple sclerosis (MS), aged from 18 to 68 years, mean 38.79 years, the mean duration of disease 122.